Krystal Biotech Inc (KRYS)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -109,727 | -145,196 | -68,275 | -32,999 | -22,081 |
| Revenue | US$ in thousands | 55,764 | 498 | — | — | — |
| Operating profit margin | -196.77% | -29,155.82% | — | — | — |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-109,727K ÷ $55,764K
= -196.77%
The operating profit margin for Krystal Biotech Inc has been highly volatile and erratic over the past five years. In 2023, the operating profit margin was -196.77%, indicating that the company's operating expenses exceeded its revenues substantially. This resulted in a significant operating loss.
The sharp decrease from -29,155.82% in 2022 to -196.77% in 2023 may suggest some improvements in controlling operating expenses relative to revenues, although the margin remains highly negative. The lack of data for 2021, 2020, and 2019 makes it challenging to assess the trend over the longer term.
The negative operating profit margins indicate that Krystal Biotech Inc is facing challenges in generating profits from its core business operations. It may be important for the company to address cost inefficiencies and explore ways to increase revenues in order to improve its overall financial performance and sustainability.
Peer comparison
Dec 31, 2023